Pharmacotherapy for bipolar depression

An economic assessment

Charles L. Bowden, Anupama A. Krishnan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Original languageEnglish
Pages (from-to)1101-1107
Number of pages7
JournalExpert Opinion on Pharmacotherapy
Volume5
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Bipolar Disorder
Economics
Drug Therapy
Cost of Illness
Mood Disorders
Suicide
Comorbidity
Maintenance
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pharmacotherapy for bipolar depression : An economic assessment. / Bowden, Charles L.; Krishnan, Anupama A.

In: Expert Opinion on Pharmacotherapy, Vol. 5, No. 5, 05.2004, p. 1101-1107.

Research output: Contribution to journalArticle

Bowden, Charles L. ; Krishnan, Anupama A. / Pharmacotherapy for bipolar depression : An economic assessment. In: Expert Opinion on Pharmacotherapy. 2004 ; Vol. 5, No. 5. pp. 1101-1107.
@article{cb5b71a53b1e4c38913a9bb7890af913,
title = "Pharmacotherapy for bipolar depression: An economic assessment",
abstract = "Bipolar disorder (BPD) is a common, severe and recurrent mood disorder associated with high rates of comorbidities, suicide, dysfunction and a high socio-economic burden. Although the management of BPD has traditionally focused on the acute treatment of mania, the chronic nature of BPD necessitates long-term maintenance treatment. Bipolar depression is the predominant abnormal affective pole and causes greater disability and economic burden than mania. Maintenance pharmacotherapy can reduce rates of future episodes, and subsequently, the associated risks, functional disability and economic burden of bipolar illness. 2004",
keywords = "Bipolar depression, Bipolar disorder, Maintenance treatment, Pharmacotherapy, Phrmacoeconomics",
author = "Bowden, {Charles L.} and Krishnan, {Anupama A.}",
year = "2004",
month = "5",
doi = "10.1517/14656566.5.5.1101",
language = "English",
volume = "5",
pages = "1101--1107",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Pharmacotherapy for bipolar depression

T2 - An economic assessment

AU - Bowden, Charles L.

AU - Krishnan, Anupama A.

PY - 2004/5

Y1 - 2004/5

N2 - Bipolar disorder (BPD) is a common, severe and recurrent mood disorder associated with high rates of comorbidities, suicide, dysfunction and a high socio-economic burden. Although the management of BPD has traditionally focused on the acute treatment of mania, the chronic nature of BPD necessitates long-term maintenance treatment. Bipolar depression is the predominant abnormal affective pole and causes greater disability and economic burden than mania. Maintenance pharmacotherapy can reduce rates of future episodes, and subsequently, the associated risks, functional disability and economic burden of bipolar illness. 2004

AB - Bipolar disorder (BPD) is a common, severe and recurrent mood disorder associated with high rates of comorbidities, suicide, dysfunction and a high socio-economic burden. Although the management of BPD has traditionally focused on the acute treatment of mania, the chronic nature of BPD necessitates long-term maintenance treatment. Bipolar depression is the predominant abnormal affective pole and causes greater disability and economic burden than mania. Maintenance pharmacotherapy can reduce rates of future episodes, and subsequently, the associated risks, functional disability and economic burden of bipolar illness. 2004

KW - Bipolar depression

KW - Bipolar disorder

KW - Maintenance treatment

KW - Pharmacotherapy

KW - Phrmacoeconomics

UR - http://www.scopus.com/inward/record.url?scp=2542572677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542572677&partnerID=8YFLogxK

U2 - 10.1517/14656566.5.5.1101

DO - 10.1517/14656566.5.5.1101

M3 - Article

VL - 5

SP - 1101

EP - 1107

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 5

ER -